Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N van Geel

Showing results (121-130 of 233) with videos related to

Pageof 24
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2022
The use of lasers in vitiligo, an overviewN F Post, N Ezekwe, V S Narayan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Outcome after surgical resections of recurrent chest wall sarcomasMichael W Wouters, Albert N van Geel, Lotte Nieuwenhuis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 8, 2013
Re-irradiation and hyperthermia after surgery for recurrent breast cancerMarianne Linthorst, Albert N van Geel, Margreet Baaijens, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic reviewV S Narayan, L L C van den Bol, N van Geel, et al.
The British Journal of Dermatology|May 13, 2014
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?I Chevolet, R Speeckaert, M Haspeslagh, et al.
Melanoma Research|March 1, 1994
Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs?J M Klaase, B B Kroon, A N van Geel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1994
Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbsB C Vrouenraets, A M Eggermont, J M Klaase, et al.
Melanoma Research|December 1, 1992
The role of regional isolated perfusion in the eradication of melanoma micrometastases in the inguinal nodes: a comparison between an iliac and femoral perfusion procedureJ M Klaase, B B Kroon, A N van Geel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limbB B Kroon, J M Klaase, B N van Geel, et al.
Annals of Surgical Oncology|December 5, 2002
Safety and efficacy of isolated limb perfusion in elderly melanoma patientsE M Noorda, B C Vrouenraets, O E Nieweg, et al.
Pageof 24

Showing results (121-130 of 233) with videos related to

Sort By:
Pageof 24
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2022
The use of lasers in vitiligo, an overviewN F Post, N Ezekwe, V S Narayan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Outcome after surgical resections of recurrent chest wall sarcomasMichael W Wouters, Albert N van Geel, Lotte Nieuwenhuis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 8, 2013
Re-irradiation and hyperthermia after surgery for recurrent breast cancerMarianne Linthorst, Albert N van Geel, Margreet Baaijens, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic reviewV S Narayan, L L C van den Bol, N van Geel, et al.
The British Journal of Dermatology|May 13, 2014
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?I Chevolet, R Speeckaert, M Haspeslagh, et al.
Melanoma Research|March 1, 1994
Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs?J M Klaase, B B Kroon, A N van Geel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1994
Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbsB C Vrouenraets, A M Eggermont, J M Klaase, et al.
Melanoma Research|December 1, 1992
The role of regional isolated perfusion in the eradication of melanoma micrometastases in the inguinal nodes: a comparison between an iliac and femoral perfusion procedureJ M Klaase, B B Kroon, A N van Geel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limbB B Kroon, J M Klaase, B N van Geel, et al.
Annals of Surgical Oncology|December 5, 2002
Safety and efficacy of isolated limb perfusion in elderly melanoma patientsE M Noorda, B C Vrouenraets, O E Nieweg, et al.
Pageof 24